Abstract

Nephrologists use recombinant human erythropoietin (epoetin) widely to treat anemia in hemodialysis patients. However, the best route of administration is uncertain. In this study, researchers randomized 208 long-term patients at 24 Veterans Affairs …

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call